RPI.4610 in Treating Patients With Metastatic Kidney Cancer
NCT00021021
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Kidney Cancer
Interventions
BIOLOGICAL:
anti-FLT-1 ribozyme
Sponsor
Ribozyome